FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462,590 | -44.1% | 218,203 | +25.4% | 0.00% | -66.7% |
| Q2 2023 | $827,954 | +104.5% | 173,940 | +144.9% | 0.00% | +200.0% |
| Q1 2023 | $404,780 | -57.2% | 71,014 | -24.3% | 0.00% | -66.7% |
| Q4 2022 | $946,816 | +144.0% | 93,837 | +442.4% | 0.00% | +50.0% |
| Q3 2022 | $388,000 | -46.6% | 17,300 | +39.2% | 0.00% | 0.0% |
| Q4 2021 | $727,000 | +42.0% | 12,430 | +100.1% | 0.00% | 0.0% |
| Q1 2021 | $512,000 | -92.9% | 6,212 | -92.2% | 0.00% | -93.8% |
| Q4 2020 | $7,213,000 | +71.4% | 79,323 | -24.7% | 0.03% | +88.2% |
| Q3 2020 | $4,209,000 | +351.6% | 105,300 | +287.6% | 0.02% | +240.0% |
| Q2 2020 | $932,000 | – | 27,167 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |